Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.06
0% from low
Exchange
OTC Link
OS
Borrow rate
29.94%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58.3K | $56.1K | $191.1K | $4.1M | $5.0M | $0 | $431.6K | $458.5K |
| Cost of revenue | $1.6K | $0 | $0 | $5.8M | $5.7M | $0 | $38.8K | $42.2K |
| Gross profit | $56.7K | $56.1K | $191.1K | −$1.7M | −$669.6K | $0 | $392.8K | $416.3K |
| Gross margin | 97.3% | 100.0% | 100.0% | -41.4% | -13.3% | — | 91.0% | 90.8% |
| R&D | $59.1K | $65.1K | $2.7M | $1.1M | $1.1M | $97.9K | $627.3K | $80.3K |
| Operating income | −$1.1M | −$1.9M | −$13.0M | −$11.9M | −$15.3M | −$6.5M | −$12.2M | −$7.8M |
| EBITDA | −$931.2K | −$1.8M | −$13.0M | −$11.9M | −$9.3M | −$6.5M | −$12.1M | −$7.8M |
| Net income | −$1.2M | −$2.9M | −$12.6M | −$12.3M | −$21.5M | −$54.6M | −$37.1M | −$16.0M |
| Net margin | -2069.8% | -5110.6% | -6590.6% | -301.1% | -425.7% | — | -8585.2% | -3485.4% |
| EPS (diluted) | -7.79 | -8.71 | -17.52 | -10.56 | -15.25 | -10.27 | -2.57 | -0.49 |
Annual figures · source: Financial Modeling Prep
CORE ONE LABS INC
No one on the platform currently holds CLABF.
No tracked institution reports a position in CLABF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-07-15 | 1-for-8reverse |
| 2020-07-08 | 1-for-2reverse |
No one on the platform has traded CLABF yet.
| $4M |
| — |
| FNAMEvolutionary Genomics, Inc. | $0.00 | +0.00% | $1331 | — |
| HAVLFHAVN Life Sciences Inc. | $0.00 | +0.00% | $2565 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.